In addition, ANGPTL2 is reportedly upregulated in tumor‐associated fibroblasts (TAFs) from anti‐VEGF‐resistant tumors (Crawford et al, 2009), suggesting that fibroblast‐derived ANGPTL2 functions in tumor development. The gene discussed is ANGPTL2; the disease is neoplasm.